Gene Query: EMD

Dataset Description Geneva Score
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 40.95
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 29.05
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 28.96
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 27.96
Impact of dieldrin on transcription in Jurkat T cells 22.25
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 21.41
mRNA expression data from ESCs derived by polar body transfer reconstructed embryos (PBTESCs) 20.87
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 19.75
RNA-seq of naive and primed ES cells (NHSM) 17.18
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 17.08
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 16.32
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 16.2
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 15.78
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 15.78
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 15.66
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 15.6
IDH3a KO RNA-seq 15.44
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 15.16
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 15.14
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 14.92
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 14.92
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 14.08
Genome wide expression change by RNF168 knocking down in MCF-7 cells 13.29
Intrahepatic MAIT cell gene expression revealed by RNA-seq 12.91
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 12.57
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 12.53
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 12.51
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 12.37
SLAM-seq for K562 endogenous mRNA decay 12.34
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 12.18
RNA-seq of Single-Cell Genotyping of Transcriptomes 12.16
Single-Cell Genotyping of Transcriptomes 12.16
The effect of Abl kinases on non-small cell carcinoma global transcriptome 12.05
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 12.03
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 11.9
Regulation of poly(A) tail and translation during the somatic cell cycle 11.89
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 11.54
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 11.31
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 11.18
EWSR1 influences alternative splicing through direct and indirect mechanisms 11.16
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 11.11
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 11.09
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 11.05
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 11.05
TGF-β regulation of miRNA expression in pancreatic cancer 10.83
Effect of Hotair overexpression in human breast cancer cell lines 10.8
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 10.74
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 10.74
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 10.5
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 10.5
Heterozygous and homozygous knock-in of PIK3CA-H1047R into human iPSCs 10.41
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 10.37
Neurofibroma 10.37
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 9.93
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 9.89
Lineage specific differentiation is influenced by state of human pluripotency [RNA-seq] 9.82
Lineage specific differentiation is influenced by state of human pluripotency 9.82
Transcriptome variation among human embryonic stem cell lines impacts on their differentiation 9.73
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 9.67
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 9.66
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 9.66
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 9.54
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 9.48
Capturing the biology of mild versus severe disease in a pluripotent stem cell-based model of Familial Dysautonomia 9.47
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 9.47
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 9.46
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 9.46
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 9.46
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 9.44
The effect of engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 9.38
High-throughput sequencing of pluripotent cells 9.29
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 9.22
Patient-derived luminal breast cancer xenografts with progestins 9.22
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 9.1
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 9.08
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 8.89
Regulation of highly expressed hCINAP on translatome 8.83
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 8.78
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 8.64
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 8.64
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 8.45
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 8.45
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 8.31
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 8.21
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 8.21
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 8.18
N6-methyladenine DNA Modification in Glioblastoma 8.18
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 8.15
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 8.15
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 7.89
Transcript abundance in A-T-derived iPSC: Comparing isogenic cells to unrelated individual 7.83
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 7.77
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 7.77
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 7.72
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 7.72
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 7.71
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 7.69
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 7.67
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 7.63
Global Mapping of Human RNA-RNA Interactions 7.54
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 7.47
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 7.44
Survival of pancreatic cancer cells lacking KRAS function 7.42
Identification of transcription start sites for human A549 cell line using ReCappable-seq 7.42
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 7.32
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 7.27
Hyper-excitability of Neurons generated from Patients with Bipolar Disorder 7.24
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 7.16
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 7.16
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast 7.15
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast 7.15
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 7.07
3’ Uridylation Expands miRNA Target Repertoire 7.0
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 6.89
Differential gene expression of human melanoma cells [RNA-seq] 6.89
Controlling for gene expression changes in transcription factor protein networks. 6.87
Whole transcriptome analysis of PBMCs stimulated with either a P. aeruginosa phage PNM lysate or with its bacterial host P. aeruginosa 6.86
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 6.85
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 6.85
Transcriptomic analysis of human tonsillar TFH subsets 6.76
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 6.76
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 6.75
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 6.73
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 6.73
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 6.71
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 6.71
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 6.69
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 6.69
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 6.65
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 6.61
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 6.61
AR-independent prostate cancer is sustained through FGF signaling 6.51
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 6.49
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 6.47
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 6.47
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 6.46
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 6.42
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 6.42
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 6.37
METTL3 and WTAP 6.3
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 6.25
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 6.25
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 6.24
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 6.24
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 6.24
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 6.23
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 6.23
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 6.18
Expression and functions of long noncoding RNAs during human T helper cell differentiation 6.14
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 6.12
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 6.11
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 6.09
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 6.04
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 5.97
Expression level comparison under dividing and quiescent states in human primary fibroblasts 5.97
In situ CAPTURE of chromatin interactions by biotinylated dCas9 5.94
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 5.94
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 5.92
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 5.92
Global transcriptome analysis of HAP1 cells 5.92
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 5.91
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 5.91
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 5.85
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 5.85
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 5.83
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 5.83
hTERT promotes cell adhesion and migration independent of telomerase activity 5.8
RNA splicing alteration on glioblastoma and normal neural stem cells 5.8
MOF acetyl transferase regulates transcription and respiration in mitochondria 5.8
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 5.77
Accurate annotation of human protein-coding small open reading frames 5.77
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 5.76
scRNASeq analysis of cycling cardiomyocytes 5.74
RNA-seq of shEZH2 cells 5.72
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 5.71
Gene expression in PANC1 cells treated with Rakicidin 5.7
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 5.7
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 5.7
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 5.66
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 5.64
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 5.64
Transcriptome analysis of BAP1 knockout and restoration 5.62
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 5.62
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 5.61
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 5.56
The human blood-nerve barrier transcriptome 5.56
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 5.52
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 5.52
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 5.51
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 5.49
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 5.48
TT-Seq captures the human transient transcriptome 5.43
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 5.42
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 5.4
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 5.39
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 5.37
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 5.36
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 5.36
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 5.27
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 5.25
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 5.25
Transcriptome of EBV-infected gastric cancer cell lines 5.22
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 5.2
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 5.19
Verification and rectification of cell type-specific splicing of a Seckel syndrome-associated ATR mutation using iPS cell model 5.19
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 5.11
Next Generation Sequencing Study of Circadian Changes in Transcriptome of Human Pineal Gland 5.07
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 5.06
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 5.0
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 4.99
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma [RNA-Seq] 4.97
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma 4.97
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 4.96
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 4.95
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 4.95
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 4.93
Gene expression changes due to PARP knockdown in human cells 4.92
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 4.91
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 4.88
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 4.86
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 4.83
The effect of spontaneous acquisition of an extra chromosome 7 for engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 4.77
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 4.73
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 4.73
Differentiation enhances Zika virus infection in neuronal brain cells 4.73
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 4.7
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 4.7
Transcriptomic analyssis following EHMT1/2 inhibition 4.69
Mutational landscape of splicing genes and functional consequences across 33 cancer types 4.69
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 4.67
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 4.67
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 4.63
Next generation sequencing of small RNAs isolated from exosomes in human semen 4.62
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 4.61
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 4.61
Transcriptome sequencing of K-562 cells 4.56
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 4.56
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 4.55
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 4.55
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 4.54
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 4.54
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 4.53
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 4.52
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 4.51
RNA-Seq in neutrophils from Antiphospholipid Syndrome 4.48
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 4.42
Genome-wide discovery of human splicing branchpoints [RNAse] 4.41
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 4.4
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 4.39
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 4.39
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 4.35
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 4.32
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 4.24
Microprocessor mediates transcription termination in long noncoding microRNA genes 4.18
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 4.15
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 4.15
Regulation of hypoxia-inducible factor activity by ZMYND8 4.06
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 3.99
Engineered human pluripotent stem cell-derived intestinal tissues with a functional enteric nervous system 3.99
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 3.96
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 3.96
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 3.92
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 3.91
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 3.9
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 3.88
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 3.85
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 3.84
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 3.84
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 3.84
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 3.81
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 3.8
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 3.75
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 3.75
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 3.73
Reversing Abnormal Neural Development by Inhibiting OLIG2 in Down Syndrome Human iPSC Brain Organoids and Neuronal Mouse Chimeras 3.68
PTHrP overexpression in MCF7 cells 3.66
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 3.59
Dynamic 3D chromosomal landscapes in acute leukemia 3.59
Intron retention induced by microsatellite expansions as a disease biomarker. 3.58
Gene expression in GBM with Cav3.2 inhibition 3.55
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 3.55
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 3.54
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 3.54
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 3.49
Genetic-to-epigenetic Therapy for Pancreatic Cancer 3.47
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 3.45
Human embryonic stem cells in E8 and AKIT culture medium 3.45
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 3.34
Ribosomal protein RPL26 is the principal target of UFMylation 3.33
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 3.32
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 3.32
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 3.32
miR941 overexpression experiment 3.3
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 3.3
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 3.29
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 3.27
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 3.27
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 3.26
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 3.26
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 3.24
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 3.2
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 3.19
ARID1A and ARID1B loss in HCT116 cells 3.06
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HCT116 cells treated with or without TNF-alpha 3.05
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 3.05
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 3.02
Ribosome profiling upon inhibition of eIF4A 2.99
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 2.97
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 2.97
Transciptomic profiling of human fetal lung samples 2.93
Effect of FGF13 depletion on the H460 cell line 2.9
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 2.89
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 2.87
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 2.86
The expression of genes encoding palmitoylated proteins in axonal and synaptic compartments is affected in CLN1/PPT1 transfected neuronal cells 2.85
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 2.84
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 2.82
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 2.82
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 2.8
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 2.8
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 2.79
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 2.73
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 2.7
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 2.7
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 2.68
Total RNA sequencing of APC mutant and wt colonic organoids 2.66
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 2.61
The DPYSL2 gene connects mTOR and schizophrenia 2.6
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 2.58
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 2.58
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 2.56
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 2.56
Genome-wide discovery of human splicing branchpoints 2.55
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 2.51
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 2.51
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 2.49
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 2.46
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 2.45
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 2.4
Co-regulation of splicing by Rbfox1 and hnRNP M 2.4
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 2.39
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 2.37
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 2.37
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 2.36
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 2.26
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 2.24
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 2.24
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 2.23
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 2.21
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 2.21
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 2.21
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 2.21
X-Ray induced DNA-Hydroxymethylation changes 2.13
m6A-dependent regulation of messenger RNA stability 2.13
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 2.1
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 2.1
RNA transcriptome analysis during HSV-1 infection 2.05
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 2.04
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 2.03
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 2.03
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 2.03
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 1.98
The Human Testis Cell Atlas via Single-cell RNA-seq (Healthy men scRNA-seq data set) 1.97
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 1.95
Functional significance of the HIV-1 Tat signature amino acid residues 1.93
Gene expression analysis in response to hypoxic pathway inhibition 1.91
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 1.88
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 1.83
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.81
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 1.78
An integrative analysis of non-coding regulatory DNA variations associated with autism 1.77
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 1.74
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 1.73
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 1.71
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 1.71
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 1.65
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 1.64
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 1.62
RNA editing in nascent RNA affects pre-mRNA splicing 1.62
Transcriptomic analysis of human neural progenitor cells differentiation into astrocytes 1.61
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 1.58
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 1.56
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 1.55
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 1.55
Positively selected enhancer elements endow tumor cells with metastatic competence 1.54
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 1.54
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 1.54
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 1.54
mRNA expression levels in splenic human mononuclear cells of mock- and HIV-1-infected humanized mice 1.53
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 1.53
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 1.52
RNASeq of mouse, human, and non-human primate primary dermal fibroblasts to poly(I:C) transfection 1.52
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 1.51
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 1.51
ARID1A and ARID1B loss in HCT116 and TOV21G cells 1.51
Derivation and differentiation of haploid human embryonic stem cells 1.48
Interaction between mitoNEET and NAF-1 in cancer cells 1.47
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 1.47
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 1.47
Derivation and differentiation of haploid human embryonic stem cells [RNA-Seq 1] 1.45
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 1.45
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 1.42
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 1.42
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 1.36
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 1.35
CD86 regulates a pro-survival signal in myeloma cells 1.29
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 1.28
A20 regulates canonical wnt-signaling through an interaction with RIPK4 1.27
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 1.24
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 1.22
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 1.21
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 1.2
EGR1-controlled transcriptome of T HESCs 1.16
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 1.15
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 1.12
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 1.1
Human neutrophil genome during PMA- and E. coli encounter-induced activation 1.1
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 1.1
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 1.08
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression 1.08
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 1.03
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 1.0
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 0.93
Tracking distinct RNA populations using efficient and reversible covalent chemistry 0.92
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 0.9
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 0.89
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 0.89
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 0.87
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 0.87
Dissecting neural differentiation regulatory networks through epigenetic footprinting 0.85
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 0.84
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 0.83
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.82
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.82
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 0.82
Effects of transcription on genome - nuclear lamina interactions 0.82
Exploring ILF2 regulatory genes by next-generation sequencing 0.8
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 0.8
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 0.79
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.78
The bromodomain protein BRD4 regulates splicing during heat shock 0.76
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 0.73
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 0.72
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 0.72
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 0.72
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 0.69
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 0.69
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 0.68
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 0.67
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 0.67
Fusion discovery in breast cancer cell line 0.66
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.64
mRNA differential expression analysis in a human ex vivo model of chronic wounds 0.64
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 0.62
Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation 0.61
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 0.6
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 0.53
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 0.52
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 0.52
MHC Transcriptomic landscape at haplotype-specific resolution 0.5
Comparative Analysis of Cas9 Activators Across Multiple Species 0.5
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 0.45
RNA-Seq analysis of human colorectal cancer with liver metastasis 0.45
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 0.45
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 0.44
RNA-Seq characterization of human H1-derived NPC differentiation timecourse 0.43
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.42
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 0.4
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 0.36
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 0.34
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 0.33
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 0.32
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 0.31
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 0.31
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 0.23
Peptidomimetic blockade of MYB in acute myeloid leukemia 0.23
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 0.23
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 0.23
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment 0.23
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment [RNA-Seq] 0.23
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 0.2
Induced DNA demethylation, genome instability and transcription 0.2
Comparative analysis of WT and ZEB1 KO cells in different stages during differentiation 0.14
Metabolism as an early predictor of DPSCs aging 0.11
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 0.1
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 0.09
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.08
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.08
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 0.07
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.06
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.06
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 0.05
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 0.04
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 0.03
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 0.03
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 0.02
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 0.02
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.02
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.02
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation